T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Walker & Dunlop
WD
$1.45B
| $24M | ﹤0.01% |
453,057
+135,566
| +43% | +$7.11M |
|
|
CMD
1102
DELISTED
Cantel Medical Corporation
CMD
| $24M | ﹤0.01% |
545,667
+12,517
| +2% | +$617K |
|
1103
Insteel Industries
IIIN
$635M
| $23.9M | ﹤0.01% |
1,275,947
+45,656
| +4% | +$859K |
|
1104
International Flavors & Fragrances
IFF
$21.4B
| $23.8M | ﹤0.01% |
194,420
-13,064
| -6% | -$1.63M |
|
1105
Employers Holdings
EIG
$864M
| $23.8M | ﹤0.01% |
786,310
-59,728
| -7% | -$1.89M |
|
1106
ADC Therapeutics
ADCT
$134M
| $23.7M | ﹤0.01% |
719,175
+126,924
| +21% | +$5.49M |
|
|
AXNX
1107
DELISTED
Axonics, Inc. Common Stock
AXNX
| $23.6M | ﹤0.01% |
463,044
+933
| +0.2% | +$38.9K |
|
1108
Blue Bird Corp
BLBD
$2.04B
| $23.5M | ﹤0.01% |
1,936,493
+234,641
| +14% | +$2.94M |
|
1109
Pacific Biosciences
PACB
$357M
| $23.5M | ﹤0.01% |
2,376,593
+2,291,714
| +2,700% | +$13.2M |
|
1110
Stepan Co
SCL
$1.48B
| $23.2M | ﹤0.01% |
212,521
+848
| +0.4% | +$92.8K |
|
1111
Cloudflare
NET
$118B
| $23.1M | ﹤0.01% |
561,483
-1,025,110
| -65% | -$39.2M |
|
1112
Expedia Group
EXPE
$39.1B
| $23M | ﹤0.01% |
251,019
-18,218
| -7% | -$1.64M |
|
1113
Kinross Gold
KGC
$32.6B
| $22.9M | ﹤0.01% |
2,599,692
-76,797
| -3% | -$664K |
|
|
HCCI
1114
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $22.7M | ﹤0.01% |
1,703,031
-1,360
| -0.1% | -$20.6K |
|
1115
eHealth
EHTH
$39.7M
| $22.7M | ﹤0.01% |
287,037
+273,620
| +2,039% | +$22.2M |
|
1116
Alector
ALEC
$228M
| $22.5M | ﹤0.01% |
2,138,922
+419,027
| +24% | +$6.78M |
|
1117
Waters Corp
WAT
$40.9B
| $22.5M | ﹤0.01% |
115,047
-7,231
| -6% | -$1.5M |
|
|
CMLFU
1118
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| $22.5M | ﹤0.01% |
+2,147,854
| New | +$22.6M |
|
1119
W.P. Carey
WPC
$16.1B
| $22.4M | ﹤0.01% |
351,482
+29,442
| +9% | +$1.98M |
|
1120
Pacira BioSciences
PCRX
$924M
| $22.4M | ﹤0.01% |
372,221
+514
| +0.1% | +$29.9K |
|
1121
Utah Medical Products
UTMD
$230M
| $22.4M | ﹤0.01% |
280,147
-13,360
| -5% | -$1.11M |
|
1122
Wintrust Financial
WTFC
$11B
| $22.2M | ﹤0.01% |
555,005
-142,041
| -20% | -$6.08M |
|
1123
Hewlett Packard
HPE
$79.2B
| $22.2M | ﹤0.01% |
2,370,899
-119,134
| -5% | -$1.14M |
|
1124
Peabody Energy
BTU
$3.01B
| $22.2M | ﹤0.01% |
9,650,224
+495,052
| +5% | +$1.43M |
|
1125
Equity Bancshares
EQBK
$1.06B
| $22.1M | ﹤0.01% |
1,424,029
-74,958
| -5% | -$1.15M |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.